Apolipoprotein E genotyping and accompanying internet-based health management system
AssigneeBerkeley HeartLab, Inc.
InventorsChristopher Hall, Vance Lanier, Jr., David T. Shewmake
Life of this patent
Estimating the term…
Abstract
The invention provides a system for monitoring a patient that includes: 1) a blood test that measures an Apo E genotype or a derivative thereof from the patient to generate Apo B information; 2) a database that receives and stores the patient's Apo E information; and 3) an Internet-based system connected to the database and configured to process the Apo E information with an algorithm that, in response, generates a diet and treatment plan for the patient.
Claims4
A method for selecting a diet plan for a patient, comprising
- (a) determining the Apo E genotype of the patient;
- and
- (b) selecting a diet plan based on the Apo E genotype of the patient;
- wherein the diet plan comprises:
- (i) a moderate-fat diet (35% fat) when the patient's Apo E genotype is e2/2 or e2/3;
- (ii) a preventative (25% fat) diet when the patient's Apo E genotype is e3/3 or e2/4;
- or
- (iii) a low-fat (20% fat) diet when the patient's Apo E genotype is e4/4 or e3/4.
A method for preventing cardiovascular disease in a patient with an increased risk of developing cardiovascular disease comprising:
- (a) determining the Apo E genotype of the patient;
- (b) prescribing a low-fat diet (20% fat) to the patient when the Apo E genotype of the patient determined from (a) is e4/4 or e3/4.
A method for preventing cardiovascular disease in a patient with an increased risk of developing cardiovascular disease comprising:
- (a) determining the Apo E genotype of the patient;
- (b) identifying the patient as having an increased risk of developing cardiovascular disease when the Apo E genotype of the patient determined from (a) is e4/4 or e3/4;
- (c) prescribing a low-fat diet (20% fat) to the patient.
A method for preventing cardiovascular disease in a patient with an increased risk of developing cardiovascular disease comprising:
- (a) determining the Apo E genotype of the patient;
- (b) identifying the patient as having an increased risk of developing cardiovascular disease when the Apo E genotype of the patient determined from (a) is e4/4 or e3/4;
- (c) selecting a low-fat diet (20% fat) for the patient identified in (b);
- and
- (d) prescribing the diet selected in step (c) to the patient.
Dependencies are inferred from the claim text.